ANG Lifesciences India Hits 52-Week Low, Receives Strong Sell Rating from MarketsMOJO
ANG Lifesciences India, a microcap pharmaceutical company, has seen a decline in its stock performance, hitting a 52-week low and receiving a Strong Sell rating from MarketsMojo. The stock is currently trading below its moving averages and has underperformed the market in the past year. Investors should carefully evaluate their options before making any decisions.
ANG Lifesciences India, a microcap pharmaceutical company, has recently hit a 52-week low on October 25, 2024. The stock, which is currently trading at Rs. 44.4, has been given a "Strong Sell" rating by MarketsMOJO.
The company's stock has been underperforming the sector by -5.82% and opened with a loss of -4.86% today. It also touched an intraday low of Rs. 44.4, which is a decrease of -7.46% from its previous close.
In terms of moving averages, ANG Lifesciences is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a downward trend in the stock's performance.
Over the past year, ANG Lifesciences has seen a decline of -33.27%, while the Sensex has shown a growth of 23.81%. This further highlights the company's underperformance in the market.
ANG Lifesciences India is a microcap company in the pharmaceutical industry. While the company's stock may be currently facing challenges, it is important to note that this is not a reflection of its future potential. Investors should carefully consider their options before making any decisions regarding this stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
